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Abstract
N-WASP (WASL) is a widely expressed cytoskeletal signalling and scaffold protein also implicated in regulation
of Wnt signalling and homeostatic maintenance of skin epithelial architecture. N-WASP mediates invasion of
cancer cells in vitro and its depletion reduces invasion and metastatic dissemination of breast cancer. Given this
role in cancer invasion and universal expression in the gastrointestinal tract, we explored a role for N-WASP in
the initiation and progression of colorectal cancer. While deletion of N-wasp is not detectably harmful in the
murine intestinal tract, numbers of Paneth cells increased, indicating potential changes in the stem cell niche, and
migration up the crypt–villus axis was enhanced. Loss of N-wasp promoted adenoma formation in an adenomatous
polyposis coli (Apc) deletion model of intestinal tumourigenesis. Thus, we establish a tumour suppressive role of
N-WASP in early intestinal carcinogenesis despite its later pro-invasive role in other cancers. Our study highlights
that while the actin cytoskeletal machinery promotes invasion of cancer cells, it also maintains normal epithelial
tissue function and thus may have tumour suppressive roles in pre-neoplastic tissues.
© 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain
and Ireland.
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Introduction
Colorectal carcinoma (CRC) is the second most com-
mon cancer in Europe, with the second highest mortality
rate [1]. In spite of advances in diagnosis and manage-
ment resulting in overall improved prognosis for patients
with CRC, survival rates remain poor for those with
advanced disease at presentation [2]. Improved under-
standing of the pathogenesis and progression of CRC is
therefore desirable, in order to mediate early diagnosis
and prevention of metastasis.
N-WASP [neural Wiskott–Aldrich syndrome protein,
also termed Wiskott–Aldrich syndrome-like (WASL)]
is a key organiser of invadopodia, actin-based struc-
tures involved in matrix remodelling [3–6]. Depletion
of N-WASP in breast cancer cells decreased invasion
and matrix remodelling [6] and led to decreased motil-
ity and metastasis [7]. Thus, N-WASP is potentially a
key target for invasion and metastasis of epithelial can-
cers. In addition to its role in cancer, N-WASP has a
scaffolding role in cell–cell adhesion and signalling in
epithelial tissues. N-WASP is a positive regulator ofWnt
pathway signalling in skin [8] and hair follicle cycling
through TGF-beta signalling [9]. N-WASP promotes the
integrity of barriers, such as the blood–testis barrier
[10], in kidney podocyte foot processes [11] and in vas-
cular permeability in the lung [12]. N-WASP also medi-
ates myoblast cell–cell fusion during myogenesis [13].
Thus, N-WASP is important for normal tissue architec-
ture and integrity, so careful consideration must be given
to whether disruption of N-WASP in cancer would have
a positive or a negative effect on progression.
The few studies of N-WASP in human cancers have
shown a correlation between increased expression of
N-WASP and poor prognosis and/or advanced stage in
pancreatic adenocarcinoma [14], hepatocellular carci-
noma [15], oesophageal squamous carcinoma [16], and
invasive ductal carcinoma of the breast [6]. Conversely,
there was decreased expression in clear cell renal cell
carcinoma, but a high level of N-WASP correlated
with poorer survival [17]. In many human cancer stud-
ies, high N-WASP expression was negatively correlated
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with survival [14,15,17]. N-WASP levels were higher in
metastatic liver lesions than in primary colonic tumours
[18]. Furthermore, the chromosomal locus of N-WASP,
7q, is amplified in 22% of colonic adenomas and 44% of
carcinomas [19]. More recently, a genome-wide asso-
ciation study identified several new susceptibility loci
for CRC, including 1p36.12, the gene locus of CDC42,
an upstream regulator of N-WASP [20]. Therefore,
N-WASP is a promising target for investigation in CRC.
To explore the role of N-WASP in intestinal home-
ostasis or CRC, we deleted N-wasp in a mouse model
involving loss of Apc (adenomatous polyposis coli),
either homozygously in the short term (3–4 days) or
heterozygously, to drive adenoma progression. We also
deleted N-wasp in a more rapid model with Apc loss in
combination with KRasG12D, which are common genetic
alterations driving human CRC [21]. Additionally, we
explored the relationship between N-WASP protein lev-
els and a range of clinicopathological parameters in two
cohorts of human CRC (early polyp cancers and more
advanced cancers). We present new evidence for a role
for N-WASP in the regulation of intestinal epithelial dif-
ferentiation and indicate that it may act as a tumour
suppressor against the development of benign precursor
lesions of CRC (adenomas).
Materials and methods
Ethics and guidelines
All mouse experiments were compliant with the Ani-
mals (Scientific Procedures) Act and UK Home Office
Regulations, and conducted with reference to the
National Centre for the Replacement, Refinement and
Reduction of Animals in Research guidelines [22].
All work involving human samples was carried
out in accordance with national and local guidelines
and with reference to the REMARK guidelines [23].
Ethical approval for the Tayside whole tissue blocks
was obtained from the Tayside Tissue Bank (request
number TR000312). For the Glasgow TMAs, ongo-
ing ethical approval for the use of the TMAs is held
by the GRI Academic Unit of Surgery (Research
Ethics Committee reference numbers 09/S0703/59 and
12/WS/0152).
Murine models
Mice were bred on a C57BL/6 background and main-
tained in a pathogen-free unit; experimental cohorts
were moved to a non-barrier unit and acclimatised for
at least 5 days before induction and monitoring. All
mice were maintained on a standard diet of Special
Diets and Services (SDS, product code 801730) and
water ad libitum. Expression of mutations was con-
trolled by a tamoxifen-inducible, gut-specific promotor,
Villin-Cre-ERT2 [24], combined with the following
alleles: Apcfl (Apc580s, MGI: Apctm1Tno) [25],
KRasG12D (MGI: KRastm4Tyj) [26], and N-waspfl
(MGI: Wasltm2Sbs) [27]. Controls in the long-term
N-wasp knockout model were a mix of genotypes, with
details of all cohorts provided in the supplementary
material, Tables S1–S3.
Tamoxifen induction
Mice were induced when they reached 20 g weight (age
range 6–18weeks across all cohorts; see supplementary
material, Tables S1–S3) with intraperitoneal injections
of tamoxifen [1 g of tamoxifen powder (Sigma-Aldrich,
Dorset, UK; Cat. No. T5648) resuspended in 10ml
of 100% ethanol (VWR Chemicals, Lutterworth,
Leics, UK; Cat. No. 20821.330) and 90ml of corn oil
(Sigma-Aldrich; Cat. No. C8267) to give a 10mg/ml
solution]. Mice received two 80mg/kg doses, 24 h apart,
except mice carrying the KRasG12D mutation, which
received one injection. The time of the first dose was
taken as ‘day 0’.
Mouse sampling
In the short-term models, mice were sacrificed on either
day 3 (mice carrying the KRasG12D mutation) or day 4
(mice with wild-type KRas) following induction. Mice
reaching the endpoint were sacrificed, and the small
intestine and colon were removed, flushed with ice-cold
water, opened longitudinally, and pinned, with the lumi-
nal surface facing upwards, on a wax-filled Petri dish.
Tissue was fixed in formalin for at least 24 h. Tumour
counts and measurements were all performed at the end-
point (see supplementary material, Table S3).
Tissue processing
Following fixation, the tissue was embedded in paraffin
and sections were cut and stained as indicated. Antibody
details are provided in Table 1. For bromodeoxyuridine
(BrdU) labelling, 2 or 24 h prior to sacrifice, mice were
injected with 250 μl of BrdU (GE Healthcare, Little
Chalfont, UK; Cat. No. RPN201) to label dividing cells
and stained with anti-BrdU antibody.
Quantification
Images were taken using the Olympus BX51 bright-
field microscope, to visualise at least 100 well-oriented
half-crypts per anatomical site per mouse. Quantifica-
tion was performed manually using the cell counter tool
in ImageJ.
Human samples
The clinical data linked to both of the Glasgow TMAs
were collected and maintained by the GRI Academic
Unit of Surgery. The early polyp cancer TMA and the
advanced cancer TMA are curated by David Mansouri
and James Park, respectively, both Clinical Lecturers
in Surgery, under the supervision of Professor Donald
McMillan, Professor of Surgical Science.
Whole tissue blocks of normal small intestine and
colon, adenoma, and adenocarcinoma were obtained
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Table 1. Details of the antibodies used for immunohistochemistry
Antibody Supplier Cat. No. Dilution Retrieval
Ki67 (SP6) rabbit monoclonal Thermo Scientific, Renfrew, UK RM-9106-S 1:100 PT Module pH 6 sodium citrate
(98 ∘C)
Synaptophysin (SY38) mouse
monoclonal
AbCam, Cambridge, UK Ab8049 1:75 PT Module pH 6 sodium citrate
(98 ∘C)
p-Erk1/2 (Thr 202/Thy 204)
rabbit polyclonal
Cell Signaling, Leiden, The Netherlands 9101 1:400 PT Module pH 6 sodium citrate
(98 ∘C)
Lysozyme rabbit polyclonal Dako, Ely, UK A099 1:1000 Proteinase K solution (10min
RT)
Caspase 3 (ASP-175) rabbit
monoclonal
Cell Signaling, Leiden, The Netherlands 9661 1:50 PT Module pH 6 sodium citrate
(98 ∘C)
BrdU mouse monoclonal BD Biosciences, Wokingham, UK 347580 1:200 PT Module pH 6 sodium citrate
(98 ∘C)
N-WASP rabbit polyclonal Sigma-Aldrich, Doset, UK HPA 005750 1:350 (mouse) 1:200 (human) PT Module pH 6 sodium citrate
(98 ∘C)
RT= room temperature.
from the Tayside Tissue Bank. Human colorectal cancer
TMAs were obtained from the Glasgow Royal Infirmary
(GRI) Academic Unit of Surgery. The early polyp can-
cer TMA contains cores from 182 patients (three cores
per tumour) who underwent resection of early T1/T2
polyp cancers as part of the NHS Bowel Screening
Programme. The advanced cancer TMA contains cores
from 272 patients (four cores per patient) who under-
went surgery for stage I–III colorectal cancer between
1997 and 2005.
TMA slides were scanned digitally at ×20 magnifica-
tion using the high-resolution Hamamatsu NanoZoomer
HT (Hamamatsu Photonics, Shizuoka, Japan) and
uploaded onto the SlidePath Digital Image Hub 4.0
(Leica Biosystems, Buffalo Grove, IL, USA). N-WASP
IHC for both TMAs was scored manually using the
weighted histoscore method [28]. Images were viewed
at ×20 magnification using the SlidePath Hub and
scores recorded within the OpTMA window. Each core
was assigned a score based on the percentage of cells
demonstrating varying degrees of positive N-WASP
staining within the cytoplasm (0= negative, 1=weak,
2=moderate, 3= strong – see supplementary material,
Figure S6A).
Analysis of publicly available datasets
To analyse N-WASP (WASL) mRNA expression in
human CRC, the TCGA (Provisional) dataset of col-
orectal cancer was examined utilising Oncomine and
cBioPortal. Using the filters Gene: WASL, Analysis
Type: Cancer vs. Normal Analysis, and Cancer Type:
Colorectal Cancer, expression values were extracted
from Oncomine and analysed in Prism. From the cBio-
Portal homepage, the query was run by selecting cancer
study ‘Colorectal Adenocarcinoma (TGCA, Provi-
sional)’ and genomic profiles ‘Putative copy-number
alterations from GISTIC’ and ‘mRNA Expression
z-scores (RNA Seq V2 RSEM)’, then entering ‘WASL’
within the ‘Enter gene set’ box. Graphs were gener-
ated by navigating to the ‘plots’ tab and selecting to
plot ‘Putative copy-number alteration’ against ‘mRNA
Expression z-scores (RNA seq V2 RSEM)’. After
analysing the resulting graph, the query was repeated
using a z-score threshold of −1.2 as the cut-off to define
cases of altered gene expression (WASL:EXP<−1.2)
and the ‘survival curve’ tab selected to display the result-
ing Kaplan–Meier curves for overall and disease-free
survival.
Statistics
All statistical analyses and graphs were created using
Prism 5 for Max OS X (GraphPad Software, Inc, San
Diego, CA, USA), except the human colorectal TMA
data, which were analysed using IBM® SPSS® Version
22 (IBM Corporation, Armonk, NY, USA), and graphs
based on these data and those exported from cBioPortal
were generated using R version 3.3.2 (The R Founda-
tion for Statistical Computing). Unless stated otherwise,
comparisons between groups were performed using a
Mann–Whitney test. All P values are unadjusted. In the
tumour model, mice culled for a reason other than reach-
ing the endpoint for the model were included in the sur-
vival analysis as censored data.
Results
N-WASP is not required for short-term homeostasis
in the intestine or colon
N-WASP is expressed along the entire length of the
epithelium of mouse intestine and colon and appears
cytoplasmic and membrane-associated (Figure 1A, B).
Deletion of N-WASP using Villin-Cre-ERT2 N-waspfl/fl
mice did not alter intestinal or colonic tissue morphol-
ogy despite a near-complete absence of N-WASP stain-
ing by day 3 (Figure 1B). Loss of N-WASP did not
affect proliferation at 4 days post-tamoxifen induction
(Figure 1C, D, black dots). The lowest BrdU-positive
cell was around 10 μm from the crypt base, regardless
of N-wasp status (p= 0.11) (supplementary material,
Figure S1A), and the highest (crypt height) at just over
80 μm (p= 0.73) (Figure 1D). There was also no differ-
ence in the number or position of BrdU-positive cells in
the colon (supplementary material, Figure S1B, C).
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Figure 1. N-WASP knockout in the intestine. (A) Representative images of N-WASP IHC in normal mouse (WT) small intestine (SI) villi and
crypts and colon. Scale bars= 20 μm. (B) Representative images of N-WASP IHC in normal (WT) mouse intestine (upper left) and colon (lower
left), and 3 days post-tamoxifen induction in N-waspfl/fl (KO) intestine (upper right) and colon (lower right). Scale bars= 100 μm. Graphs C–I
show time points at 4 days (black) and 1 year (red) post-tamoxifen induction in wild-type (WT) and N-waspfl/fl (KO) intestine as indicated. (C)
Number of BrdU-positive cells per half crypt/villus unit. (D) Intestinal crypt height (measured as distance of highest BrdU-positive cell from
crypt base). (E) Number of goblet cells (GCs) per half crypt/villus unit. (F) Number of enteroendocrine cells (EECs) per 100 half crypt/villus
units. (G) Number of Paneth cells (PCs) per half crypt/villus unit. (H) Position of highest Paneth cell (measured as distance from crypt base).
(I) Length of crypt/villus (measured from crypt base to villus tip). All graphs: n= 3–6 mice, counting 100 half crypts/villi per sample. Error
bars= SEM. *p< 0.05 (Mann–Whitney). †Crypt= half crypt/villus unit.
In general, specialised cell types were unaffected by
N-WASP loss by day 4 after induction, as the num-
ber of goblet cells [GCs, Alcian blue and periodic
acid-Schiff (ABPAS)-positive] (Figure 1E, black dots),
enteroendocrine cells (EECs, synaptophysin-positive)
(Figure 1F, black dots), and Paneth cells (PCs,
lysozyme-positive) (Figure 1G, black dots) was
unchanged. Localisation of Paneth cells within the
crypt–villus axis (assessed by measuring the height
of the highest lysozyme-positive cell from the crypt
base) by day 4 following induction (Figure 1H, black
dots) was also unchanged. There was also no effect
on apoptosis (cleaved caspase-3-positive) (supplemen-
tary material, Figure S1D, black dots) or villus length
(Figure 1I). Thus, N-WASP is expressed throughout
the epithelium of the intestine and colon and its loss
does not affect morphology, proliferation, apoptosis, or
differentiation or distribution of specialised cell types
in the short term.
At 1 year post-induction, N-WASP depletion is
sustained, although focal expression was observed
(supplementary material, Figure S1E). Prolifer-
ation (Figure 1C, D and supplementary material,
Figure S1A–C, red dots) and apoptosis (supplementary
material, Figure S1D, red dots) were unaffected at
1 year following N-WASP loss. However, small but sta-
tistically significant increases in both Paneth and goblet
cell numbers, but not enteroendocrine cell numbers
© 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2018
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Figure 2. N-WASP knockout does not affect intestinal epithelial proliferation in a rapid model. (A) IHC for BrdU at 2 and 24 h following
intraperitoneal BrdU injection in Apcfl/fl (A) and Apcfl/flN-waspfl/fl (AN) intestines. Scale bars= 50 μm. (B) IHC for BrdU at 2 and 24 h in Apcfl/fl
KRasG12D/+ (AK) and Apcfl/fl KRasG12D/+N-waspfl/fl (AKN) intestines. Scale bars= 50 μm. (C) Number of BrdU-positive cells per half crypt/villus
unit as indicated. (D) Intestinal crypt height (measured as distance of highest BrdU-positive cell from crypt base). (E) Cell migration along
the crypt–villus axis as assessed by change in position of the highest BrdU-positive cell at 2 h (black) and 24 h (red) as indicated. All graphs:
n= 4–5 mice, counting 100 half crypts/villi per sample. Error bars= SEM. *p< 0.05 (Mann–Whitney). †Crypt= half crypt/villus unit.
or position of the highest Paneth cell, were observed
(Figure 1E–H, red dots). There was also an increase in
villus length (Figure 1I, red dots) from 338.0±13.73 to
483.5±39.30 (p= 0.0105). Thus, we conclude that loss
of N-WASP causes only minor perturbations of normal
intestinal epithelial homeostasis and can be sustained
up to 1 year.
Loss of N-WASP results in increased intestinal
epithelial cell migration
Normally, epithelial cells of the intestine are in constant
flux from the crypt area, where they arise up toward
the top of the villus and eventually slough off [29,30].
This movement is referred to as migration along the
crypt–villus axis and is driven by proliferation, but also
involves differential expression of integrins and matrix
ligands along the axis [29,30]. We tested the effect of
N-wasp deletion on this migration by treating mice with
BrdU and measuring the position of the cells along this
axis at 2 and 24 h post-injection. Loss ofN-wasp acceler-
ated the migration of BrdU-labelled cells both in young
and in older mice (supplementary material, Figure S1F,
G). Deletion of Apc abrogates the migration of epithe-
lial cells along the intestinal crypt–villus axis [31], and
in the context of homozygous Apc deletion (Figure 2A)
or Apc deletion combined with additional KRasG12D
mutation (Figure 2B), additional loss of N-wasp did
not accelerate migration (Figure 2E). Loss of Apc also
increases proliferation and crypt height [31], neither
of which was affected by additional loss of N-wasp
© 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2018
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Figure 3. Effect of N-WASP knockout on small intestinal Paneth cells in a rapid model at 4 days post-induction. (A) Representative images
of IHC for lysozyme to identify Paneth cells in wild-type (WT), Apcfl/flKRasG12D/+ (AK), and Apcfl/flKRasG12D/+N-waspfl/fl (AKN) mice. Scale
bars= 50 μm. (B) Number of Paneth cells (PCs) per half crypt/villus unit as indicated. (C) Position of highest Paneth cell (measured as
distance from crypt base) as indicated. For B and C: n= 4–5, counting 100 half crypts/villi per sample. Error bars= SEM. *p< 0.05. ns= not
significant (Mann–Whitney). †Crypt= half crypt/villus unit.
(Figure 2C, D). Thus, the effect of Apc deletion was
stronger than that of N-wasp deletion. Loss of N-wasp
had no effect on proliferation in the colon (supplemen-
tary material, Figure S2A, B).
Loss of N-WASP alters differentiation and migration
in a model of short-term homozygous Apc deletion
Homozygous loss of Apc in the intestine is lethal, but
in the short term extensive hyperproliferation caused by
total Apc loss can be studied up to 4 days past induction
[31]. Loss of Apc increases the number of Paneth cells
and the height of their spread along the crypt–villus axis
[31] (Figure 3A–C). Loss ofN-wasp increased the num-
ber and position of Paneth cells in the crypt–villus axis,
on a background of combined loss of Apc with expres-
sion of KRasG12D (Figure 3A–C). Interestingly, this is
similar to, but even more marked than, the alterations
in Paneth and goblet cell numbers seen in N-waspfl/fl
mice at 1 year post-induction (Figure 1E, G, H). Loss
of Apc slightly decreased the number of goblet cells,
but this was restored by loss of N-wasp (supplemen-
tary material, Figure S2C). This effect was negligible
in the presence of KRasG12D (supplementary material,
Figure S2C). There was no effect of N-wasp deletion
on the number of enteroendocrine cells (supplementary
material, Figure S2D) or apoptotic cells (supplementary
material, Figure S2E) in any of the genotypes. Thus,
N-wasp loss promoted increased Paneth cell numbers,
which potentially could affect the Lgr5+ stem cell niche
[32,33].
N-Wasp knockout increased tumour burden
and decreased survival in an Apc-deficient model
of tumourigenesis
Heterozygous deletion of Apc drives the formation of
adenomas (benign tumours) and microadenomas (very
small tumours not visible to the naked eye – examples
of histology are provided in the supplementary mate-
rial, Figure S4A) in the small intestine of mice with a
long latency; combining Apc loss with expression of
mutant KRasG12D accelerates this progression by around
three- to four-fold [34,35]. Heterozygous Apc deletion
induced tumours in mice with a median survival of
around 271 days, but N-wasp loss accelerated progres-
sion (median survival 143 days; Figure 4A, black line).
Addition of KRasG12D/+ accelerated progression further
(median survival 65.5 days), which was not significantly
shortened by loss of N-wasp (55.5 days) (Figure 4B,
black line). Loss of N-wasp together with heterozy-
gous Apc loss resulted in significantly more tumours
in the small intestine by the endpoint (Figure 4C).
However, in the colon, there was a small decrease
in the number of tumours in the Apcfl/+ N-waspfl/fl
mice (supplementary material, Figure S3A). Although
Apcfl/+ N-waspfl/fl mice showed more intestinal tumours
compared with Apcfl/+ controls, the average tumour
size was reduced (Figure 4D). There was no significant
N-WASP-dependent difference in the size of colonic
tumours (supplementary material, Figure S3B) or
Ki67 (proliferation marker) expression (supplementary
material, Figure S3C). The number and size of intestinal
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Figure 4. Loss of N-WASP accelerates an Apc heterozygous loss model of intestinal tumourigenesis. (A) Kaplan–Meier survival curves (days
since induction) for Apcfl/+ (A, red line, n= 14) and Apcfl/+N-waspfl/fl (AN, black line, n= 17) mice. P value derived from log-rank test.
(B) Kaplan–Meier survival curves (days since induction) for Apcfl/+KRasG12D/+ (AK, red line, n= 10) and Apcfl/+KRasG12D/+N-waspfl/fl (AKN,
black line, n= 12) mice. P value derived from log-rank test. (C) Total intestinal tumour counts for Apcfl/+ (A, n= 13) and Apcfl/+N-waspfl/fl
(AN, n= 15) mice. Error bars= SEM. ***p< 0.001 (Mann–Whitney). (D) Average intestinal tumour area in Apcfl/+ (A) and Apcfl/+N-waspfl/fl
(AN) mice. n= 5. Error bars= SEM. *p< 0.05 (Mann–Whitney). (E) Representative image of intestinal tumour from Apcfl/+ mouse. Scale
bar= 200 μm. (F) Representative image of intestinal tumour from Apcfl/+N-waspfl/fl mouse. Scale bar= 200 μm.
tumours in Apcfl/+ KRasG12D/+ mice were independent
of N-wasp status (supplementary material, Figure S3D,
E); however, there was a small but significant decrease
in the number of tumours in the colon (supplementary
material, Figures S3F, G). There were no morphologi-
cal differences between tumours in Apcfl/+ and Apcfl/+
N-waspfl/fl intestinal and colonic tumours (Figure 4E,
F and supplementary material, Figure S4A, B). Thus,
loss of N-wasp accelerated the effects of Apc depletion
by increasing the number of tumours. This suggests a
possible tumour suppressor function for N-WASP in the
early stages of colorectal cancer.
N-WASP expression is correlated with disease-free
survival in human colorectal cancer
Data obtained from Oncomine™ (Compendia
Bioscience, Ann Arbor, MI, USA) showed significantly
© 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2018
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Figure 5. N-WASP in human colorectal cancer – online data mining. (A) N-WASP (WASL) mRNA expression z-score levels in colorectal
cancer (CRC) compared with control tissue (normal). Error bars= SEM. ***p< 0.001 (Mann–Whitney). (B) mRNA expression z-scores of
N-WASP (WASL) in the TCGA (Provisional) dataset by copy number status. −1.2 was chosen as the cut-off for low N-WASP expression. (C,
D) Survival curves for patients from the TCGA dataset stratified by N-WASP (WASL) mRNA z-score versus (C) disease-free survival (DFS)
and (D) overall survival (OS). Black lines represents patients with N-WASP mRNA z-score ≤ 1.2 (low expression) and red lines represents
cases with z-score ≥ 1.2. (normal/high expression). P value derived from log-rank test.
lower expression of N-WASP mRNA in cancer versus
normal tissue for 7/12 CRC datasets using a cut-off of
p ≤ 0.01, 1.5-fold, and the top 10% of underexpressed
genes. Specifically, in the TCGA (Provisional) cohort,
there was a statistically significant decrease in the
expression of N-WASP mRNA in CRC versus normal
colorectal tissue (p< 0.001, Figure 5A).
The TCGA Provisional (http://cancergenome.nih
.gov/) dataset was also examined using cBioPortal
(Figure 5B) and we generated Kaplan–Meier survival
curves of patients with low (z-score<−1.2) and nor-
mal/high (z-score ≥ −1.2) N-WASP mRNA expression.
In this dataset, low N-WASP expression was associated
with a statistically significant decrease in disease-free
survival (p= 0.016) (Figure 5C) and a trend towards
poorer overall survival (Figure 5D), although not
statistically significant (p= 0.06).
N-WASP expression is correlated
with differentiation and possible T stage in human
early-stage polyp cancers
Tissue from the Tayside Tissue Bank revealed that
N-WASP was largely cytoplasmic in human small
intestine (supplementary material, Figure S5A) and
colon (supplementary material, Figure S5B), and was
expressed at moderate to high levels in the epithelium
throughout the length of the crypt–villus axis. Like-
wise, N-WASP showed variable intensity in human
benign adenomas of the colon (supplementary material,
Figure S5C) and in adenocarcinoma (supplemen-
tary material, Figure S5D). Subsequent approval was
obtained from the NHS Greater Glasgow and Clyde
Biorepository for access to two Glasgow Royal Infir-
mary Academic Unit of Surgery colorectal TMAs. The
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first (screen-detected TMA) contains cores from 182
patients (three cores per tumour) who had undergone
resection of early T1/T2 polyp cancers identified via the
NHS Bowel Screening Programme, while the second
(non-screen-detected TMA) contains cores from 272
patients (four cores per tumour) who underwent surgery
for stage I–III CRC between 1997 and 2005.
The patient demographics and clinicopathological
features of the tumours are summarised in the sup-
plementary material, Table S4. The TMA was stained
for N-WASP and scored using a weighted histoscore
method (supplementary material, Figure S6A). Patients
were divided into groups according to their N-WASP
histoscores relative to the median. Chi-squared anal-
ysis revealed a correlation between N-WASP expres-
sion and age under 65 years at diagnosis (p= 0.007),
which may reflect genetic differences in CRCs present-
ing in younger patients (supplementary material, Table
S5). As screening starts from age 50 in Scotland, our
cohort had an age range of 50–76 years and a mean age
of 65.72 years. Poorly differentiated tumours (n= 4) all
expressed high levels of N-WASP (p= 0.044). As this
TMA was only recently constructed, survival data are
not available as most patients are still living.
N-WASP is correlated with MMR (DNA mismatch
repair) status but not with survival in human
colorectal cancers
N-WASP was analysed in the non-screen-detected
TMA – a cohort of 272 colorectal cancer patients who
underwent surgical resection between 1997 and 2005
(stage I–III cancers). The patient demographics and
clinicopathological features of the tumours included
in the cohort are summarised in the supplementary
material, Table S6. The correlation between N-WASP
and a number of clinicopathological characteristics was
again compared by chi-squared analysis (supplementary
material, Table S7). The only statistically significant
correlation was between low N-WASP histoscore and
MMR deficiency. Patients were again divided into
groups according to their N-WASP histoscores. There
was no difference in cancer-specific (Figure 6A) or
overall (Figure 6B) survival between patients with high
and low histoscores. When patients were stratified by
Dukes stage, there was a divergence of the curves (sup-
plementary material, Figure S6B), with a trend towards
better cancer-specific survival in Dukes B patients with
the highest histoscores; however, there were only 70
patients and seven events in this subgroup, and the
results were not statistically significant (p= 0.118). We
therefore cautiously suggest that further investigation
of N-WASP expression in a larger clinical cohort is
warranted.
Discussion
Although expressed at moderate levels throughout
normal intestinal epithelium, N-WASP knockout in
Figure 6. N-WASP in human colorectal cancer – TMA. (A)
Cancer-specific survival curves (months since surgery) and (B)
overall survival curves for patients with tumours with high (median
and above, red line, n= 75) and low (below median, black line,
n= 78) epithelial IHC histoscores for N-WASP. P value derived
from log-rank test.
intestinal epithelial cells gave a surprisingly mild phe-
notype, with no obvious morphological changes. Loss
of N-WASP resulted in a slight increase in the number of
Paneth and goblet cells and further displacement of their
position along the crypt-villus axis than that caused by
Apc loss alone. Loss of N-WASP also increased the dis-
tance that cells migrated up along the crypt–villus axis
over 24 h. Migration up the crypt–villus axis is thought
to be driven mainly by proliferation [30], so this result
was surprising as loss of N-WASP did not alter prolif-
eration. Previous studies found differential expression
of integrins and matrix components in crypt–villus
regions, which might impact on migration through
differential adhesion [36,37]. N-WASP is also required
for matrix remodelling in cancer cells [6,7], so might be
© 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2018
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important for epithelial cell interactions with the base-
ment membrane. N-WASP deletion provides perhaps
the first demonstration of a case where migration of
intestinal epithelial cells is impacted without alteration
of proliferation rates and suggests that the cytoskeleton
may be important in crypt–villus migration.
The Paneth cell is a source of Wnt in the intestine
and maintains a niche for Lgr5+ stem cells [32,33]
as well as secreting antimicrobial compounds to pro-
tect against pathogens and maintain the barrier function
[38]. Although Paneth cell numbers were only slightly
increased in N-wasp knockouts, this might be signif-
icant as the number and location of Paneth cells are
tightly regulated in normal epithelium [39–41]. Fur-
thermore, Paneth cells and goblet cells develop from
a common precursor [42], suggesting why both might
increase. N-WASP regulates differentiation and matura-
tion of lymphocytes [27,43], pancreatic β cells [44], and
hair follicle progenitor cells [8]. The data presented here
suggest that it may have a similar role in cell fate in the
intestinal epithelium.
In the Apcfl/+ model, N-wasp knockout increased
tumour burden and decreased survival. N-wasp knock-
out Apcfl/+ animals developed multiple microadenomas,
as well as a few larger lesions (supplementary material,
Figure S4). Increased Paneth cell numbers might thus
support more tumour-originating cells [45]. However,
preliminary studies using RNA in situ hybridisation did
not show anyN-WASP-dependent difference in the loca-
tion of Lgr5+ stem cells within small intestinal villi in
any of our models (data not shown).
Although N-wasp knockouts harboured more small
lesions, there was no difference in the size of the largest
individual tumour or proliferation rate. As mice gener-
ally reach the endpoint due to a large tumour causing
obstruction of the bowel lumen, this suggests that the
difference in survival between the two cohorts is due
to earlier initiation of tumourigenesis in N-wasp knock-
outs. Apc loss alone will increase the proliferative abil-
ity of intestinal epithelial cells but further mutations
are required in order for tumours to progress to cancer.
Therefore, N-WASPmay have a tumour suppressive role
in early lesions.
Although there is very little known about a role
for N-WASP in the GI tract, it stabilises epithelial
adherens junctions in cultured cells [46]. Competent
adherens junctions may pose a mechanical impedi-
ment to adenoma formation in Apc-deficient tissue,
suggesting that destabilisation could promote progres-
sion [46]. However, we did not detect any signifi-
cant changes in architecture or E-cadherin staining (not
shown) of normal or tumour tissue when N-wasp was
deleted. No difference in survival or intestinal tumour
burden was observed between Apcfl/+ KRasG12D/+ and
Apcfl/+ KRasG12D/+ N-waspfl/fl mice. Previous research
has shown that oncogenic Ras causes a reduction in
adherens junction formation, lending further support to
the proposed model [47].
In the early cancer TMA, all of the poorly differ-
entiated tumours showed a high N-WASP histoscore.
There was also a possible correlation between N-WASP
histoscore and T stage but this did not reach statisti-
cal significance. Returning to this cohort at a later time
could provide more samples and help to assess the use
of N-WASP histoscore as a prognostic indicator for
early cancers. Within the advanced cancer TMA cohort,
the only significant correlation was that MMR-deficient
tumours had a greater frequency of low than of high
N-WASP histoscores. There was no difference in over-
all or cancer-specific survival between patients with high
or low histoscores. However, subgroup analysis revealed
poorer survival in patients with Dukes stage A tumours
and high epithelial N-WASP histoscores and Dukes B
tumours with low histoscores, although the differences
were not statistically significant. The lack of statistical
significance, however, may be related to the small sam-
ple size, as there were only 14 Dukes A patients and
70 Dukes B patients, so the results do not definitively
exclude N-WASP as a prognostic indicator. Indeed, the
findings from the database searches of Oncomine and
cBioPortal show decreased expression of both APC and
N-WASP in colorectal adenomas and carcinomas, and
that lower N-WASP expression is associated with poorer
survival. The clinicopathological data available via such
methods, however, are very limited and it would be
worthwhile to explore N-WASP in a larger TMA cohort
to explore its usefulness as a prognostic biomarker in
clinical practice.
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